Gene · 3326
Papers4,343
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,343
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of the first geldanamycin-based HSP90 degraders. | Front Chem | 2023 | 37448856 | PubTator, text mining | PubMed |
| Mass Spectrometry as a Quantitative Proteomic Analysis Tool for the Search for Temporal Lobe Epilepsy Biomarkers: A Systematic Review. | Int J Mol Sci | 2023 | 37446307 | PubTator, text mining | PubMed |
| Expression-Based Diagnosis, Treatment Selection, and Drug Development for Breast Cancer. | Int J Mol Sci | 2023 | 37445737 | PubTator, text mining | PubMed |
| Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications. | Cancers (Basel) | 2023 | 37444544 | PubTator, text mining | PubMed |
| Single-cell profiling reveals distinct immune response landscapes in tuberculous pleural effusion and non-TPE. | Front Immunol | 2023 | 37435066 | PubTator, text mining | PubMed |
| Senescence-related gene c-Myc affects bladder cancer cell senescence by interacting with HSP90B1 to regulate cisplatin sensitivity. | Aging (Albany NY) | 2023 | 37433010 | PubTator, text mining | PubMed |
| RAB11A and RAB11B control mitotic spindle function in intestinal epithelial progenitor cells. | EMBO Rep | 2023 | 37424454 | PubTator, text mining | PubMed |
| PARP1 negatively regulates transcription of BLM through its interaction with HSP90AB1 in prostate cancer. | J Transl Med | 2023 | 37415147 | PubTator, text mining | PubMed |
| Identification and quantification of protein nitration sites in human coronary artery smooth muscle cells in the absence and presence of peroxynitrous acid/peroxynitrite. | Redox Biol | 2023 | 37413764 | PubTator, text mining | PubMed |
| Proliferation, migration, and resistance to oxidative and thermal stresses of HT1080 cells with knocked out genes encoding Hsp90α and Hsp90β. | Biochem Biophys Res Commun | 2023 | 37406487 | PubTator, text mining | PubMed |
| Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes. | Genes Dis | 2023 | 37397541 | PubTator, text mining | PubMed |
| Carbonic anhydrase IX inhibitor S4 triggers release of DAMPs related to immunogenic cell death in glioma cells via endoplasmic reticulum stress pathway. | Cell Commun Signal | 2023 | 37386564 | PubTator, text mining | PubMed |
| How chromosomal translocations arise to cause cancer: Gene proximity, trans-splicing, and DNA end joining. | iScience | 2023 | 37378346 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in the Pathogenesis of Hematological Malignancies: Interaction with Tumor Microenvironment; a Potential Biomarker and Targeted Therapy. | Biomolecules | 2023 | 37371477 | PubTator, text mining | PubMed |
| Globally invariant behavior of oncogenes and random genes at population but not at single cell level. | NPJ Syst Biol Appl | 2023 | 37355674 | PubTator, text mining | PubMed |
| Mutations F352A and Y528A in human HSP90α reduce fibronectin association and fibrillogenesis in cell-derived matrices. | Cell Stress Chaperones | 2023 | 37353709 | PubTator, text mining | PubMed |
| Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation. | Nat Commun | 2023 | 37353488 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative Breast Cancer by Integrated Bioinformatical Analysis. | Anticancer Res | 2023 | 37351977 | PubTator, text mining | PubMed |
| CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1. | Pathol Oncol Res | 2023 | 37351538 | PubTator, text mining | PubMed |
| Retraction Note: Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma. | Oncogene | 2023 | 37344628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3326/papers?page=25